# Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis

> **NCT02541045** · PHASE3 · WITHDRAWN · sponsor: **Hospital General de Mexico**

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** metadoxine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02541045
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-08
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of resources to finance the project
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541045, "Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT02541045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*